Human Abelson murine leukemia viral oncogene homolog 1 (Abl-1), GenBank Accession No. NM_005157, a.a. 229-512, with Thr-to-Ile mutation on a.a. 315* and N-terminal His-tag, MW = 33 kDa, expressed in a baculovirus-infected Sf9 cell expression system. *This mutation is often cited as T334I in variant B (GenBank Accession No. NM_007313).

P00519

Abl-1(T315I), Abl-1(T344I), ABL1, Abelson murine leukemia viral oncogene homolog 1, JTK7

222 pmoles/min/μg.

Activity was determined using a 100% phosphorylated Tyr02 peptide and a Z-lyte kinase assay (Invitrogen). Reaction was incubated at 30°C for 1 hour.

25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 20% glycerol, and 3 mM DTT.

Aqueous buffer solution

>6 months at –80°C.

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.

1. Cao, C., et al. 2003. J. Biol. Chem. 278(15): 12961–7.
2. Yano, H., et al. 2000. J. Neurosci. Res. 59(3): 356–364.

This protein was previously named as Abl Kinase Mutant (T334I), His-tag. The protein has not changed; however, the standard nomenclature for numbering this protein has been revised, based on PDB Accession number 2V7A_A.

Avoid freeze/thaw cycles

Kinase/Receptor Tyrosine

Recombinant Protein